Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer
Article
Refaat, Tamer, Choi, Mehee, Gaber, Germaine et al. (2014). Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer
. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 37(5), 480-485. 10.1097/COC.0b013e31827e4e9a
Refaat, Tamer, Choi, Mehee, Gaber, Germaine et al. (2014). Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer
. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 37(5), 480-485. 10.1097/COC.0b013e31827e4e9a